Browse result page of CancerPDF Database
Please click on CancerPDF_ID for detailed information about peptide.
| CancerPDF_ID | Peptide seq | Protein Name | Fluid | Mass/Z | Profiling Technique | Cancer Type | Expression Regulation | PUBMED ID |
|---|---|---|---|---|---|---|---|---|
| CancerPDF_ID99 | AVPPNNSNAAEDDLPTVELQGVVPR | Factor XIIIa | Serum | 2602.15 | MALDI-TOF | Metastatic thyroid carcinomas | NA | 16896061 |
| CancerPDF_ID200 | AVPPNNSNAAEDDLPTVELQGVVPR | Coagulation factor XIIIA | Serum | 2602.3048 | MALDI-TOF | "Non-small cell lung cancer (NSCLC) patients, who were treated with first-line chemotherapy" | Peptide Ion Signature for differentiation between Short PFS(Progression Free survival) versus long PFS | 19728888 |
| CancerPDF_ID1095 | AVPPNNSNAAEDDLPTVELQGVVPR | Factor XIIIa | Serum | 2602.15 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =2.84, 2.3 and 4.73 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID2045 | AVPPNNSNAAEDDLPTVELQGVVPR | Coagulation factor XIII A chain | Serum | 2601.30346 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID2046 | RAVPPNNSNAAEDDLPTVELQGVVPR | Coagulation factor XIII A chain | Serum | 2757.40457 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID2047 | TAFGGRRAVPPNNSNAAEDDLPTVELQGVVPR | Coagulation factor XIII A chain | Serum | 3346.70181 | LC-MS | Colorectal cancer | Differentially expressed between cancer vs normal | 21136997 |
| CancerPDF_ID2048 | NNSNAAEDDLPTVELQGVVPR | Coagulation factor XIII A chain | Serum | 2237.0924 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID2049 | VPPNNSNAAEDDLPTVELQGVVPR | Coagulation factor XIII A chain | Serum | 2530.26635 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID2203 | GGPEAAKSDETAA | Heat-shock protein beta-1 | Serum | 1202.54151 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID2204 | ESRAQLGGPEAAKSDETAA | Heat-shock protein beta-1 | Serum | 1886.897 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID2205 | EGSDDEEEG | Splicing factor 3 subunit 1 | Serum | 965.30978 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID2260 | DGERHAFILQDTK | Factor XIII | Serum | 1528.76341 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID9635 | DLPTVELQGVVPR | Coagulation factor XIII A chain | Serum | 711.9 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9636 | NNSNAAEDDLPTVE | Coagulation factor XIII A chain | Serum | 744.81 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9637 | DDLPTVELQGVVPR | Coagulation factor XIII A chain | Serum | 769.41 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9638 | EDDLPTVELQGVVPR | Coagulation factor XIII A chain | Serum | 833.93 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9639 | AEDDLPTVELQGVVPR | Coagulation factor XIII A chain | Serum | 869.45 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9640 | NAAEDDLPTVELQGVVPR | Coagulation factor XIII A chain | Serum | 641.65 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9641 | NNSNAAEDDLPTVELQGVVPR | Coagulation factor XIII A chain | Serum | 746.68 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9642 | VPPNNSNAAEDDLPTVELQGVVPR | Coagulation factor XIII A chain | Serum | 844.41 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9643 | AVPPNNSNAAEDDLPTVELQGVVPR | Coagulation factor XIII A chain | Serum | 868.08 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9644 | RAVPPNNSNAAEDDLPTVELQGVVPR | Coagulation factor XIII A chain | Serum | 920.12 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9645 | TAFGGRRAVPPNNSNAAEDDLPTVELQGVVPR | Coagulation factor XIII A chain | Serum | 837.66 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID12719 | AVPPNNSNAAEDDLPTVELQGVVPR | Coagulation factor XIII A chain | Serum | 2602.306 | MALDI-TOF | Breast cancer | "Upregulated with the fold change of 0.47 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.04, Upregulated in BC vs healthy with 1.073 fold change" | 27058005 |